Diabetic neuropathy is the most common complication of diabetes mellitus. Among the large number of drugs used as symptomatic therapy to reduce its manifestations, alpha-lipoic acid medications are specific for providing pathogenic effect on many mechanisms of diabetic neuropathy. The article provides an overview of studies on the use of alpha-lipoic acid in the treatment of diabetic neuropathy
Background: Neuropathic pain is difficult to treat. We identified those studies in the literature in...
Background: Neuropathic pain is difficult to treat. We identified those studies in the literature in...
International audienceDiabetes is a chronic metabolic disease with a high prevalence worldwide. Diab...
The article highlights the questions of pathogenesis and treatment of diabetic neuropathy — one of t...
The increase in the number and life expectancy of patients with diabetes mellitus (DM) worldwide det...
The article is devoted to the treatment of diabetic neuropathy. The described scheme of application ...
Both oral and intravenous administration of alpha-lipoic acid (ALA) has been investigated as add-on ...
Diabetic neuropathy represents late diabetes complications, and diabetes duration and long-term hype...
Diabetes mellitus is one of the frequent diseases. The article describes diabetic neuropathy as the ...
The article details the pathogenesis of diabetic polyneuropathy (DPN) and tells about the stages and...
Diabetes mellitus is one of the emergency situations worldwide. DM is the most common cause of neuro...
The most common form of peripheral nervous system damage in diabetes mellitus is distal symmetric se...
Background: Neuropathic pain is difficult to treat. We identified those studies in the literature in...
In our country, alpha-lipoic acid is widely used as a pathogenetic therapy for diabetic polyneuropat...
Background: Neuropathic pain is difficult to treat. We identified those studies in the literature in...
Background: Neuropathic pain is difficult to treat. We identified those studies in the literature in...
Background: Neuropathic pain is difficult to treat. We identified those studies in the literature in...
International audienceDiabetes is a chronic metabolic disease with a high prevalence worldwide. Diab...
The article highlights the questions of pathogenesis and treatment of diabetic neuropathy — one of t...
The increase in the number and life expectancy of patients with diabetes mellitus (DM) worldwide det...
The article is devoted to the treatment of diabetic neuropathy. The described scheme of application ...
Both oral and intravenous administration of alpha-lipoic acid (ALA) has been investigated as add-on ...
Diabetic neuropathy represents late diabetes complications, and diabetes duration and long-term hype...
Diabetes mellitus is one of the frequent diseases. The article describes diabetic neuropathy as the ...
The article details the pathogenesis of diabetic polyneuropathy (DPN) and tells about the stages and...
Diabetes mellitus is one of the emergency situations worldwide. DM is the most common cause of neuro...
The most common form of peripheral nervous system damage in diabetes mellitus is distal symmetric se...
Background: Neuropathic pain is difficult to treat. We identified those studies in the literature in...
In our country, alpha-lipoic acid is widely used as a pathogenetic therapy for diabetic polyneuropat...
Background: Neuropathic pain is difficult to treat. We identified those studies in the literature in...
Background: Neuropathic pain is difficult to treat. We identified those studies in the literature in...
Background: Neuropathic pain is difficult to treat. We identified those studies in the literature in...
International audienceDiabetes is a chronic metabolic disease with a high prevalence worldwide. Diab...